Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

OBJECTIVE—To define a safe and effective dose of Dysport for treating hip adductor spasticity.
METHODS—Patients with definite or probable multiple sclerosis, and disabling spasticity affecting the hip adductor muscles of both legs, were randomised to one of four treatment groups. Dysport (500, 1000,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hyman, N, Barnes, M, Bhakta, B, Cozens, A, Bakheit, M, Kreczy-Kleedorfer, B, Poewe, W, Wissel, J, Bain, P, Glickman, S, Sayer, A, Richardson, A, Dott, C
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2000
Témata:
Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736956/
https://ncbi.nlm.nih.gov/pubmed/10811692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.68.6.707
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky